Ramón
Lecumberri Villamediana
Consultor Médico
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (9)
2024
-
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
Neurologia, Vol. 39, Núm. 9, pp. 721-732
2021
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Leukemia, Vol. 35, Núm. 1, pp. 245-249
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2020
-
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature
Amyloid, Vol. 27, Núm. 3, pp. 163-167
2019
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
2017
-
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9
2013
-
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study
Thrombosis Research, Vol. 132, Núm. 6, pp. 666-670
-
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: Data from the RIETE registry
Respiratory Research, Vol. 14, Núm. 1
2007
-
Haemodynamically unstable pulmonary embolism in the RIETE Registry: Systolic blood pressure or shock index?
European Respiratory Journal, Vol. 30, Núm. 6, pp. 1111-1116